Immunoglobulin G, Anti-(Human Calcitonin Gene-Related Peptide Receptor) (Human Monoclonal Heavy Chain), Disulfide With Human Monoclonal Light Chain, Dimer
Cluster Headache Syndrome
Charite University, Berlin, Germanymonoclonal_antibodyPhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Cluster Headache Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Galcanezumab Eli Lilly and Company | Phase 3 | BB |
Marcaine Stanford University | Phase 2 | CCC |
Pasireotide Novartis Pharmaceuticals | Phase 2 | CCC |
Oxygen The University of Texas Health Science Center, Houston | Phase 1 | CC |
Ketorolac Weill Medical College of Cornell University | Phase 1 | CC |
View all 9 →
Same molecule, other indications
Immunoglobulin G, Anti-(Human Calcitonin Gene-Related Peptide Receptor) (Human Monoclonal Heavy Chain), Disulfide With Human Monoclonal Light Chain, Dimer is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →